Frontiers in Psychiatry | Molecular Psychiatry

Original Research

Published on 27 Mar 2024

Parvalbumin interneuron deficiency in the prefrontal and motor cortices of spontaneously hypertensive rats: an attention-deficit hyperactivity disorder animal model insight

in Molecular Psychiatry

Ewelina Bogdańska-Chomczyk
Maciej Równiak
Andrew Chih-Wei Huang
Anna Kozłowska

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1359237

2,517 views
3 citations

Original Research

Published on 18 Mar 2024

Lower serum insulin-like growth factor 2 level in patients with bipolar disorder is associated with the severity of manic symptoms during manic episodes

in Molecular Psychiatry

Shi-Yi Ye
Ying Zhao
Zhao-Bo Liu
Cui-Pin Luo
Jian-Wen Xiong
Jin-Qiong Zhan
Yi-Heng Li
Bo Wei
Chun-Nuan Chen
Yuan-Jian Yang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1354999

1,627 views
2 citations

Case Report

Published on 25 Jan 2024

Case report: A case of anti-recoverin antibody-positive encephalitis exhibiting Cotard and Capgras delusions that was successfully treated with electroconvulsive therapy

in Molecular Psychiatry

Takaki Akahane
Naomi Takahashi
Ryota Kobayashi
Konoka Nomura
Masakazu Akiho
Yukihiro Shikama
Keisuke Noto
Akihito Suzuki

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1330745

4,140 views
4 citations

Editorial

Published on 08 Jan 2024

Editorial: Back to the future: on the road towards precision psychiatry, volume II

in Molecular Psychiatry

Paul C. Guest
Stefan Borgwardt
Johann Steiner

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1355085

1,024 views

Editorial

Published on 08 Jan 2024

Editorial: Genome-wide molecular mechanisms of substance use disorders

in Molecular Psychiatry

Ilya O. Blokhin
David M. Martinez-Garza
Dhruti Patel
Antoine B. Douaihy
Ihsan M. Salloum

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1356103

1,037 views

Original Research

Published on 05 Jan 2024

Multilevel evidence of MECP2-associated mitochondrial dysfunction and its therapeutic implications

in Molecular Psychiatry

Peter Balicza
Andras Gezsi
Mariann Fedor
Judit C. Sagi
Aniko Gal
Noemi Agnes Varga
Maria Judit Molnar

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1301272

2,875 views
3 citations

Mini Review

Published on 21 Dec 2023

From cells to insights: the power of human pluripotent stem cell-derived cortical interneurons in psychiatric disorder modeling

in Molecular Psychiatry

Peiyan Ni
Lingyi Fan
Youhui Jiang
Chuqing Zhou
Sangmi Chung

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1336085

2,538 views
2 citations

Original Research

Published on 14 Dec 2023

Mitochondrial DNA oxidation, methylation, and copy number alterations in major and bipolar depression

in Molecular Psychiatry

Deniz Ceylan
Bilge Karacicek
Kemal Ugur Tufekci
Izel Cemre Aksahin
Sevin Hun Senol
Sermin Genc

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1304660

3,882 views
5 citations

Original Research

Published on 29 Nov 2023

Effect of brain acidification on depression-related behaviors in diabetes mellitus

in Molecular Psychiatry

Yusuke Temma
Kisho Obi-Nagata
Yoshio Hoshiba
Ryuhei Miyake
Yuta Katayama
Hideo Hagihara
Norimitsu Suzuki
Tsuyoshi Miyakawa
Keiichi I. Nakayama
Akiko Hayashi-Takagi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1277097

2,467 views

Mini Review

Published on 24 Nov 2023

Second-generation antipsychotics and metabolic syndrome: a role for mitochondria

in Molecular Psychiatry

Katherine R. H. Mortimer
Mohammed Zia Ul Haq Katshu
Lisa Chakrabarti

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1257460

7,921 views
6 citations

Original Research

Published on 17 Oct 2023

A whole exome sequencing study to identify rare variants in multiplex families with alcohol use disorder

in Molecular Psychiatry

Shirley Y. Hill
Joseph Hostyk

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1216493

2,358 views
7 citations

Review

Published on 03 Oct 2023

Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2—Metabolome, immunome, synaptome

in Molecular Psychiatry

Albert Stuart Reece
Gary Kenneth Hulse

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1182536

3,725 views
1 citation

Review

Published on 02 Oct 2023

Inflammation and viral infection as disease modifiers in schizophrenia

in Molecular Psychiatry

Hans C. Klein
Paul C. Guest
Henrik Dobrowolny
Johann Steiner

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1231750

4,827 views
8 citations

Editorial

Published on 27 Sep 2023

Editorial: Molecular pathology in psychiatric diseases: frontiers of postmortem brain research

in Molecular Psychiatry

Yasuto Kunii
Mizuki Hino
Hiroaki Tomita

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1286182

1,484 views

Original Research

Published on 15 Sep 2023

Association of interleukin-6 with suicidal ideation in veterans: a longitudinal perspective

in Molecular Psychiatry

Shengnan Sun
Caroline M. Wilson
Sharon Alter
Yongchao Ge
Erin A. Hazlett
Marianne Goodman
Rachel Yehuda
Hanga Galfalvy
Fatemeh Haghighi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1231031

1,792 views
3 citations

Review

Published on 05 Sep 2023

Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1–aging and epigenomics

in Molecular Psychiatry

Albert Stuart Reece
Gary Kenneth Hulse

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1182535

3,807 views
1 citation